Analystreport

Vascular Biogenics Ltd (NASDAQ: VBLT) was given a new $3.00 price target on by analysts at Chardan Capital. They now have a "hold" rating on the stock.

Vascular Biogenics Ltd. - Ordinary Shares  (VBLT) 
Last vascular biogenics ltd. - ordinary shares earnings: 11/14 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: vblrx.com